Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.690
0.00 (0.00%)
Nov 6, 2025, 2:36 PM EST - Market open
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $11.89 million as of November 6, 2025. Its market cap has decreased by -4.08% in one year.
Market Cap
11.89M
Enterprise Value
-489.18K
1-Year Change
-4.08%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since November 5, 2015, Edesa Biotech's market cap has decreased from $74.90M to $11.89M, a decrease of -84.12%. That is a compound annual growth rate of -16.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 11.90M | 105.17% |
| Dec 31, 2024 | 5.80M | -60.00% |
| Dec 29, 2023 | 14.50M | -65.31% |
| Dec 30, 2022 | 41.80M | -45.07% |
| Dec 31, 2021 | 76.10M | 70.25% |
| Dec 31, 2020 | 44.70M | 45.13% |
| Dec 31, 2019 | 30.80M | 528.57% |
| Dec 31, 2018 | 4.90M | -42.35% |
| Dec 29, 2017 | 8.50M | -58.74% |
| Dec 30, 2016 | 20.60M | -62.34% |
| Dec 31, 2015 | 54.70M | -26.97% |
| Nov 5, 2015 | 74.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.38B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |